Angiodynamics (ANGO) Non-Current Assets (2011 - 2026)
Angiodynamics' (ANGO) quarterly Non-Current Assets came in at $103.8 million in Q2 2026, down 7.2% on a YoY basis from $111.8 million in Q2 2025, and down 1.29% quarter-over-quarter from $105.1 million in Q1 2026.
Analysis
Angiodynamics (ANGO) Non-Current Assets (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has reported Non-Current Assets for 16 consecutive years, with $103.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 7.2% year-over-year to $103.8 million; the trailing twelve-month figure through May 2026 stood at $426.2 million (down 7.79% YoY), and the FY2026 full-year result was $103.8 million, down 7.2% from the prior year.
- Non-Current Assets eased to $103.8 million in Q2 2026 per ANGO's latest filing, from $105.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $415.5 million in Q1 2022 and bottomed at $103.8 million in Q2 2026.
- Historically, Non-Current Assets has averaged $231.3 million across 5 years, with a median of $126.2 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets slipped 2.65% in 2022, then tumbled 67.22% in 2024.
- Over 5 years, Non-Current Assets stood at $399.4 million in 2022, then slipped by 21.34% to $314.2 million in 2023, then tumbled by 63.0% to $116.2 million in 2024, then declined by 6.8% to $108.3 million in 2025, then decreased by 4.21% to $103.8 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $103.8 million, $105.1 million, and $108.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Angiodynamics | 626.21 Mn | 572.35 Mn | 46.77 Mn | 103.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 103.77 Mn |
| Feb 28, 2026 | 105.13 Mn |
| Nov 30, 2025 | 108.33 Mn |
| Aug 31, 2025 | 108.99 Mn |
| May 31, 2025 | 111.82 Mn |
| Feb 28, 2025 | 113.14 Mn |
| Nov 30, 2024 | 116.24 Mn |
| Aug 31, 2024 | 121.03 Mn |
| May 31, 2024 | 124.42 Mn |
| Feb 29, 2024 | 127.94 Mn |
| Nov 30, 2023 | 314.16 Mn |
| Aug 31, 2023 | 318.47 Mn |
| May 31, 2023 | 369.10 Mn |
| Feb 28, 2023 | 390.28 Mn |
| Nov 30, 2022 | 399.38 Mn |
| Aug 31, 2022 | 406.33 Mn |
| May 31, 2022 | 409.41 Mn |
| Feb 28, 2022 | 415.49 Mn |
| Nov 30, 2021 | 421.92 Mn |
| Aug 31, 2021 | 424.44 Mn |